Search for New Potential T-Cell and B-Cell Epitopes in the Spike Protein of SARS-CoV-2

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

The current epidemiological situation, including the existence of new SARS-CoV-2 virus with a high mutagenicity, requires fundamentally new deadlines for the development of vaccines, which may be achieved only applying modern computing technologies and simulation. Epitopes have been found in the spike protein of the SARS-CoV-2 virus using immunoinformatics methods, and their allergenicity and immunogenecity was predicted. It is shown that a vaccine against SARS-CoV-2 can be designed based on these epitopes.

Sobre autores

I. Kolesnikov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

V. Timofeev

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

M. Nikolenko

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

A. Ermakov

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

A. Ivanovsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

Yu. Dyakova

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва

Yu. Pisarevsky

Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia; National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia

Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

M. Kovalchuk

National Research Centre “Kurchatov Institute”, 123182, Moscow, Russia; Shubnikov Institute of Crystallography, Federal Scientific Research Centre “Crystallography and Photonics,” Russian Academy of Sciences, 119333, Moscow, Russia

Autor responsável pela correspondência
Email: a.1wanowskiy@gmail.com
Россия, Москва; Россия, Москва

Bibliografia

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses // Nat Microbiol. 2020. V. 5 (4). P. 536. https://doi.org/10.1038/s41564-020-0695-z
  2. Beeching N.J., Fletcher T.E., Flower R. // BMJ Best Practice Coronavirus Disease (COVID-19).
  3. Heymann D.L., Shido N. // Lancet. 2020. V. 395 (10224). P. 542. https://doi.org/10.1016/S0140-6736(20)30374-3
  4. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance, WHO, 2020, 28 January.
  5. Araf Y., Moin A.T., Timofeev V.I. et al. // Front. Immunol. 2022. V. 13. 863234. https://doi.org/10.3389/fimmu.2022.863234
  6. Abass O.A., Timofeev V.I., Sarkar B. et al. // J. Biomolecular Structure and Dynamics. 2021. V. 40 (16). P. 7283. https://doi.org/10.1080/07391102.2021.1896387
  7. Quarleri J., Galvan V., Delpino M.V. // GeroScience. 2022. V. 44 (1). P. 53. https://doi.org/10.1007/s11357-021-00500-4
  8. Gowrisankar A., Priyanka T.M., Banerjee S. // Eur. Phys. J. Plus. 2022. V. 137. P. 100. https://doi.org/10.1140/epjp/s13360-021-02321-y
  9. Yao L., Zhu K. L., Jiang X. L. et al. // Lancet. Infectious Diseases. 2022. V. 22. № 8. P. 1116. https://doi.org/10.1016/S1473-3099(22)00410-8
  10. Cao Y., Yisimayi A., Jian F. et al. // Nature. 2022. V. 608 (7923). P. 593. https://doi.org/10.1038/s41586-022-04980-y
  11. Gallagher T.M., Buchmeier M.J. // Virology. 2001. V. 279. № 2. P. 371.
  12. Larsen M.V., Lundegaard C., Lamberth K. et al. // BMC Bioinformatics. 2007. V. 8. 424. https://doi.org/10.1186/1471-2105-8-424
  13. Buus S., Lauemoller S.L., Worning P. et al. // Tissue Antigens. 2003. V. 62. № 5. P. 378.
  14. Potocnakova L., Bhide M., Pulzova L.B. // J. Immunol. Res. 2016. 6760830. https://doi.org/10.1155/2016/6760830
  15. Ponomarenko J., Bui H.H., Li W. et al. // BMC Bioinformatics. 2008. V. 9. 514. https://doi.org/10.1186/1471-2105-9-514
  16. Dimitrov I., Bangov I., Flower D.R., Doytchinova I. // J. Mol. Model. 2014. V. 20. 2278. https://doi.org/10.1007/s00894-014-2278-5
  17. Gupta S., Kapoor P., Chaudhary K. et al. // PLoS ONE. 2013 V. 8 (9). № 73957. https://doi.org/10.1371/journal.pone.0073957
  18. Doytchinova I.A., Flower D.R. // BMC Bioinformatics. 2007. V. 8 (4). https://doi.org/10.1186/1471-2105-8-4
  19. Kudriavtsev A.V., Vakhrusheva A.V., Novoseletsky V.N. et al. // Viruses. 2022. V. 14 (8). 1603. https://doi.org/10.3390/v14081603
  20. Hallgren J., Konstantinos D.T., Pedersen M.D. et al. // bioRxiv. 2022. https://doi.org/10.1101/2022.04.08.487609
  21. Sharma N., Naorem L.D., Jain S., Raghava G.P.S. // Briefings in bioinformatics. 2022. V. 23. № 5. 174. https://doi.org/10.1093/bib/bbac174

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
2.

Baixar (473KB)
3.

Baixar (29KB)
4.

Baixar (541KB)
5.

Baixar (461KB)
6.

Baixar (393KB)

Declaração de direitos autorais © Russian Academy of Sciences, 2023